Fleetwood Mac's John McVie diagnosed with cancer; band cance - KCTV5

Fleetwood Mac's John McVie diagnosed with cancer; band cancels tour

By Alan Duke, CNN
updated 1:13 PM EDT, Sun Oct 27, 2013

STORY HIGHLIGHTS

  • Fleetwood Mac was to tour Australia and New Zealand in November and December
  • John McVie will undergo cancer treatments over the next two months, group says
  • No details of McVie's cancer were revealed
  • Original members returned to touring last April after a three-year break

LOS ANGELES (CNN) -- Fleetwood Mac co-founder John McVie has been diagnosed with cancer, forcing the group to cancel upcoming shows on its world tour.

The band just completed the European leg of the tour and had been scheduled to perform 14 shows in Australia and New Zealand in November and December.

An announcement on the band's Facebook page did not disclose details about McVie's cancer, only saying that the 67-year-old is "now scheduled to be in treatment for cancer during that period of time."

"We are sorry to not be able to play these Australian and New Zealand dates," the announcement said. "We hope our Australian and New Zealand fans as well as Fleetwood Mac fans everywhere will join us in wishing John and his family all the best."

Original members of the group -- including Lindsey Buckingham, Mick Fleetwood, John McVie and Stevie Nicks -- returned to touring last April after a three-year break from the road.

They toured the United States first, then traveled to Europe.

Their classic 1977 "Rumours" album was rereleased earlier this year with unreleased studio and live tracks.

John McVie and Mick Fleetwood started the group in 1967.

CNN's John Branch contributed to this report.

Article on CNN.com

CNN © 2013 Cable News Network.Turner Broadcasting System, Inc. All Rights Reserved.
Powered by WorldNow
KCTV 5 News

Online Public File:
KCTV  KSMO

Powered by WorldNow CNN
All content © 2014, KCTV; Kansas City, MO. (A Meredith Corporation Station) and WorldNow. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.